STOCK TITAN

MariMed (MRMD) CCO exercises RSUs, withholds shares for taxes and updates stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MARIMED INC. Chief Commercial Officer Ryan Crandall reported routine equity compensation activity. On June 15, 2026, Restricted Stock Units (RSUs) covering 250,000 shares were exercised into common stock, and a portion of the resulting shares was withheld to cover tax obligations. Following these transactions, Crandall directly holds 1,189,429 shares of common stock and 750,000 RSUs. The RSUs were granted on December 15, 2025 and the remaining units are scheduled to vest in three equal installments on December 15, 2026, June 15, 2027 and December 15, 2027.

Positive

  • None.

Negative

  • None.
Insider Crandall Ryan
Role Chief Commercial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units (RSU) 250,000 $0.00 --
Exercise Common stock 250,000 $0.00 --
Tax Withholding Common stock 86,626 $0.069 $6K
Holdings After Transaction: Restricted Stock Units (RSU) — 750,000 shares (Direct, null); Common stock — 1,189,429 shares (Direct, null)
Footnotes (1)
  1. RSUs convert to shares of common stock on a one-for-one basis. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. The RSUs were granted on December 15, 2025; the remaining RSUs under this grant will vest in three equal installments on each of December 15, 2026, June 15, 2027 and December 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
RSUs exercised 250,000 shares Restricted Stock Units converting to common stock on June 15, 2026
Shares withheld for taxes 86,626 shares Common stock withheld to satisfy tax obligations on RSU vesting
Common shares after transactions 1,189,429 shares Direct holdings of common stock following June 15, 2026 activity
RSUs remaining 750,000 RSUs Restricted Stock Units held after the reported transactions
RSU grant date December 15, 2025 Grant date of the RSUs referenced in the filing
Future vesting dates Dec 15, 2026; Jun 15, 2027; Dec 15, 2027 Scheduled RSU vesting in three equal installments
Tax withholding price $0.069 per share Price per share used for tax-withholding disposition of common stock
Restricted Stock Units (RSU) financial
"The RSUs were granted on December 15, 2025; the remaining RSUs under this grant will vest..."
tax withholding obligations financial
"Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations..."
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vest financial
"the remaining RSUs under this grant will vest in three equal installments..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
award agreement financial
"in accordance with the terms of an award agreement between the Issuer and the Reporting Person."
An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Crandall Ryan

(Last)(First)(Middle)
C/O MARIMED INC.
10 OCEANA WAY

(Street)
NORWOOD MASSACHUSETTS 02062

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock06/15/2026M250,000A$0(1)1,189,429D
Common stock06/15/2026F86,626(2)D$0.0691,102,803D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (RSU)(1)06/15/2026M250,000 (3) (3)Common Stock, par value $.001 per share250,000$0750,000D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. The RSUs were granted on December 15, 2025; the remaining RSUs under this grant will vest in three equal installments on each of December 15, 2026, June 15, 2027 and December 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Remarks:
/s/ Ryan Crandall06/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MARIMED INC. (MRMD) report for Ryan Crandall?

MARIMED INC. reported that Chief Commercial Officer Ryan Crandall exercised RSUs for 250,000 shares of common stock. Some of the resulting shares were withheld to satisfy tax obligations related to the vesting, reflecting routine equity compensation activity rather than an open-market trade.

How many MARIMED INC. (MRMD) shares does Ryan Crandall hold after this Form 4?

After the reported transactions, Ryan Crandall directly holds 1,189,429 shares of MARIMED INC. common stock. He also holds 750,000 Restricted Stock Units, which represent additional potential shares that will convert into common stock as they vest over time.

Were any MARIMED INC. (MRMD) shares sold on the market in this Form 4?

No open-market sales were reported. The filing shows shares of MARIMED INC. common stock were withheld by the company to cover tax obligations tied to RSU vesting, which is a tax-related disposition rather than a discretionary sale into the public market.

What RSU grant is involved in Ryan Crandall’s MARIMED INC. (MRMD) Form 4?

The Form 4 involves Restricted Stock Units granted to Ryan Crandall on December 15, 2025. These RSUs convert to common stock on a one-for-one basis as they vest, providing equity-based compensation aligned with MARIMED INC.’s long-term performance.

When will Ryan Crandall’s remaining MARIMED INC. (MRMD) RSUs vest?

The remaining RSUs from the December 15, 2025 grant are set to vest in three equal installments. The scheduled vesting dates are December 15, 2026, June 15, 2027 and December 15, 2027, according to the award agreement between MARIMED INC. and Crandall.

What does the tax withholding in the MARIMED INC. (MRMD) Form 4 indicate?

The tax withholding indicates MARIMED INC. retained 86,626 shares of common stock to satisfy Ryan Crandall’s tax obligations on RSU vesting. This is a standard mechanism where shares are used instead of cash to pay required taxes on equity compensation.